Holen Sie sich die Stockscreener-App
25.00
0.04%
0.01
Handel nachbörslich:
25.00
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Eton Pharmaceuticals, Inc. (ETON) stock price, news, quote and history - Yahoo Finance UK
How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets - Yahoo Finance
(ETON) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Eton Pharmaceuticals Inc (ETON) Stock Price, Quote, News & History - Benzinga
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week HighHere's Why - marketbeat.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 14.4% in March - marketbeat.com
JPMorgan Chase & Co. Has $7.64 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON - marketbeat.com
ETON Stock Price, Quote & Chart | ETON PHARMACEUTICALS INC (NASDAQ:ETON) - ChartMill
Layoff Watch: Can Eton Pharmaceuticals Inc maintain sales growth2026 Big Picture & Community Verified Trade Alerts - baoquankhu1.vn
Breakout Move: Is Eton Pharmaceuticals Inc forming a breakout patternMarket Activity Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
The Insider Report: Markets Wade into Geopolitical Abyss - Benzinga
Eton Pharmaceuticals (ETON) price target increased by 25.56% to 38.42 - MSN
Vanguard (ETON) Disaggregates Holdings, Reports 0 Shares - Stock Titan
Eton Pharmaceuticals (ETON) Jumps 6.7%: Does the Stock Have More Room to Grow? - Bitget
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Does Eton Pharmaceuticals (ETON) have the potential to rally 49.25% as Wall Street analysts expect? - MSN
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High After Analyst Upgrade - MarketBeat
Recent price trend in Eton Pharmaceuticals (ETON) is your friend, here's why - MSN
H.C. Wainwright raises Eton Pharmaceuticals price target on growth goals By Investing.com - Investing.com Canada
Recent Price Trend in Eton Pharmaceuticals (ETON) is Your Friend, Here's Why - Yahoo Finance
Dow Update: Is Eton Pharmaceuticals Inc still a buy after recent gainsMarket Performance Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Zacks Research Upgrades Eton Pharmaceuticals (NASDAQ:ETON) to Strong-Buy - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Eton Pharmaceuticals Maps Aggressive Rare-Disease Growth Path - TipRanks
Eton Pharmaceuticals receives Investment Bank Analyst Rating Update By Investing.com - Investing.com Canada
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
B. Riley Financial Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect? - sharewise.com
Does Eton Pharmaceuticals (ETON) Have a Chance to Surge 49.25% According to Wall Street Analysts' Predictions? - Bitget
B.Riley raises Eton Pharmaceuticals stock price target on strong Q4 results - Investing.com Canada
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript - Insider Monkey
Eton Pharma 2025 Financial Results & 2026 Outlook | Product Launches Drive GrowthNews and Statistics - IndexBox
Portfolio Update: Can Eton Pharmaceuticals Inc. lead its sector in growth2026 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Eton Pharmaceuticals 2023 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals 2025 Annual Report: Rare Disease Drug Portfolio, Regulatory Pathways, and Risk Factors Overview - Minichart
Is Eton Pharmaceuticals Inc a cyclical or defensive stock2026 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Eton Pharmaceuticals, Inc. (ETON) Q4 earnings lag estimates - MSN
Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Eton Pharmaceuticals, Inc. (ETON) Q4 Results Fall Short of Projections - Bitget
ETON: 2025 revenue more than doubled year-over-year, with strong margin gains and robust growth outlook - TradingView
Eton Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Eton Pharma (ETON) Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Eton Pharmaceuticals Q4 2025 beats EPS, stock rises - Investing.com
Eton Pharmaceuticals earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Eton Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - tradingview.com
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Posts Mixed Q4 2025 Results with Revenue Beat and EPS Miss - chartmill.com
ETON PHARMACEUTICALS ($ETON) Releases Q4 2025 Earnings - quiverquant.com
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
ETON: 2025 revenues doubled to $80M, but higher costs led to a net loss; growth expected ahead - TradingView
Eton Pharmaceuticals (NASDAQ: ETON) outlines rare-disease drugs, pipeline and IRA pricing risks - Stock Titan
Eton Pharmaceuticals (NASDAQ: ETON) posts strong 2025 growth and bullish 2026 outlook - Stock Titan
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):